Jamie O’Hara

1.5k total citations
67 papers, 951 citations indexed

About

Jamie O’Hara is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Jamie O’Hara has authored 67 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 12 papers in Genetics and 6 papers in Surgery. Recurrent topics in Jamie O’Hara's work include Hemophilia Treatment and Research (54 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Jamie O’Hara is often cited by papers focused on Hemophilia Treatment and Research (54 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Jamie O’Hara collaborates with scholars based in United Kingdom, United States and Switzerland. Jamie O’Hara's co-authors include Charlotte Camp, Tom Burke, Liz Carroll, Shaun Walsh, Brian O’Mahony, Lars Wilkinson, Giuseppe Mazza, Mark W. Skinner, David Hughes and Nanxin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Acta Psychiatrica Scandinavica.

In The Last Decade

Jamie O’Hara

57 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamie O’Hara United Kingdom 16 691 123 119 89 81 67 951
Jan Brzezicki Poland 8 252 0.4× 25 0.2× 129 1.1× 83 0.9× 32 0.4× 12 909
Peter Joosten Netherlands 10 212 0.3× 58 0.5× 110 0.9× 40 0.4× 17 0.2× 18 527
Anna Jamnitski Netherlands 8 147 0.2× 53 0.4× 71 0.6× 42 0.5× 25 0.3× 9 617
Smolen Js Austria 11 165 0.2× 65 0.5× 43 0.4× 23 0.3× 34 0.4× 30 654
Kejal Parikh United States 10 446 0.6× 280 2.3× 113 0.9× 21 0.2× 41 0.5× 40 634
S Bagnulo Italy 13 84 0.1× 183 1.5× 58 0.5× 91 1.0× 182 2.2× 23 633
G. Lukina Russia 11 157 0.2× 30 0.2× 142 1.2× 30 0.3× 16 0.2× 94 633
Anca Prica Canada 14 141 0.2× 119 1.0× 147 1.2× 27 0.3× 16 0.2× 130 609
Bénédicte Delcoigne Sweden 12 93 0.1× 43 0.3× 49 0.4× 29 0.3× 21 0.3× 45 554
H. Goldschmidt Germany 11 265 0.4× 147 1.2× 60 0.5× 21 0.2× 35 0.4× 34 447

Countries citing papers authored by Jamie O’Hara

Since Specialization
Citations

This map shows the geographic impact of Jamie O’Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie O’Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie O’Hara more than expected).

Fields of papers citing papers by Jamie O’Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie O’Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie O’Hara. The network helps show where Jamie O’Hara may publish in the future.

Co-authorship network of co-authors of Jamie O’Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie O’Hara. A scholar is included among the top collaborators of Jamie O’Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie O’Hara. Jamie O’Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chowdary, Pratima, Richard Ofori‐Asenso, Francis Nissen, et al.. (2024). Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs. SHILAP Revista de lepidopterología. 8(2). e181–e193.
3.
Burke, Tom, Talaha M Ali, Nanxin Li, et al.. (2022). Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B. Journal of Medical Economics. 25(1). 386–392. 4 indexed citations
4.
Li, Nanxin, Eileen K. Sawyer, Gregory F. Guzauskas, et al.. (2021). Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model. Journal of Medical Economics. 24(1). 363–372. 8 indexed citations
5.
Bullinger, Monika, Hannah B Lewis, Wolfgang Miesbach, et al.. (2021). The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia. SHILAP Revista de lepidopterología. 8(1). 56–68. 4 indexed citations
6.
O’Hara, Jamie, Antony P. Martin, Diane J. Nugent, et al.. (2021). Evidence of a disability paradox in patient‐reported outcomes in haemophilia. Haemophilia. 27(2). 245–252. 33 indexed citations
7.
Burke, Tom, et al.. (2021). Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US+ population surveys. Orphanet Journal of Rare Diseases. 16(1). 143–143. 28 indexed citations
9.
Castro, Felipe A., et al.. (2020). Disease burden and remaining unmet need in patients with haemophilia A treated with primary prophylaxis. Haemophilia. 27(1). 113–119. 24 indexed citations
10.
Pedra, Gabriel, et al.. (2020). The impact of factor infusion frequency on health-related quality of life in people with haemophilia. SHILAP Revista de lepidopterología. 7(1). 102–109. 3 indexed citations
11.
O’Hara, Jamie. (2020). Examining the Hemophilia Disability Paradox. 2 indexed citations
12.
Martin, Antony P., et al.. (2020). PMU95 A Systematic Literature Review of Preference Studies in Haemophilia. Value in Health. 23. S619–S619. 1 indexed citations
13.
Martin, Antony P., James E. Thomson, L Richardson, et al.. (2020). PRO124 Qualitative Research to Inform the Development of a Discrete Choice Experiment to Examine Preferences of People with Haemophilia for GENE Therapy. Value in Health. 23. S712–S712.
14.
O’Hara, Jamie, et al.. (2018). Long‐term outcomes from prophylactic or episodic treatment of haemophilia A: A systematic review. Haemophilia. 24(5). e301–e311. 20 indexed citations
16.
O’Hara, Jamie, Shaun Walsh, Charlotte Camp, et al.. (2018). The impact of severe haemophilia and the presence of target joints on health-related quality-of-life. Health and Quality of Life Outcomes. 16(1). 84–84. 93 indexed citations
17.
Camp, Charlotte, Jamie O’Hara, David Hughes, & Jim Adshead. (2017). Short-term Outcomes and Costs Following Partial Nephrectomy in England: A Population-based Study. European Urology Focus. 4(4). 579–585. 21 indexed citations
18.
Mazza, Giuseppe, et al.. (2016). The Impact of Haemophilia Complications on Health-Related Quality of Life for Adults with Severe Haemophilia. Value in Health. 19(7). A593–A593. 3 indexed citations
19.
Hirst, Ceri, et al.. (2016). Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age. Value in Health. 19(7). A592–A593. 1 indexed citations
20.
Giunti, Paola, Julie Greenfield, Michael Parkinson, et al.. (2013). Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany. Orphanet Journal of Rare Diseases. 8(1). 38–38. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026